However, recent findings indicate that improved survival highly correlates with the frequency of DNAM-1+CD56dim NK and NKp46+CD56dim NK cells after treatment with anti-CTLA-4 in patients with malignant mesothelioma (125). The gene discussed is CD226; the disease is malignant mesothelioma.